Unknown

Dataset Information

0

Reliability of Drug History to Verify Androgen Abuse in Men.


ABSTRACT:

Context

Clinical evaluations that require excluding androgen abuse, a secretive, illicit activity, rely on the drug history, but its veracity for androgen abuse has neither been verified nor has any objective corroborating laboratory test been validated.

Objective

In a high-risk population, to (a) validate the drug history of androgen abuse objectively using state-of-the-art World Anti-Doping Agency-accredited antidoping laboratory urine mass spectrometry tests and (b) to determine what biochemical tests best distinguish androgen abuse from nonuse in this population.

Methods

Urine samples from current (n = 41) and past (n = 31) androgen abusers and nonusers (n = 21) were analyzed by comprehensive mass spectrometry-based detection tests for androgens and related drugs (ARD).

Results

No prohibited ARDs were identified among nonusers. Current users had a median of 5 (range 1-13) drugs detected comprising 176 ARDs among 220 drug identifications. Past users had a median of 1 (range 0-9) drugs detected comprising 21 ARDs among 43 drugs. Negative predictive value was high (>0.8) for those denying drug usage while positive predictive value was good (>0.6) for both those reporting currently using (current) and not using (nonusers plus past users) ARD. Serum luteinizing hormone (LH) alone had high, but imperfect, discriminatory power (89%) to distinguish between current and noncurrent androgen use.

Conclusions

We demonstrates that a negative drug history in a high-risk group has high reliability and that even a single suppressed serum LH exhibits high discrimination for objectively detecting androgen abuse.

SUBMITTER: Shankara-Narayana N 

PROVIDER: S-EPMC9387685 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Reliability of Drug History to Verify Androgen Abuse in Men.

Shankara-Narayana Nandini N   Brooker Lance L   Goebel Catrin C   Speers Naomi N   Handelsman David J DJ  

The Journal of clinical endocrinology and metabolism 20220801 9


<h4>Context</h4>Clinical evaluations that require excluding androgen abuse, a secretive, illicit activity, rely on the drug history, but its veracity for androgen abuse has neither been verified nor has any objective corroborating laboratory test been validated.<h4>Objective</h4>In a high-risk population, to (a) validate the drug history of androgen abuse objectively using state-of-the-art World Anti-Doping Agency-accredited antidoping laboratory urine mass spectrometry tests and (b) to determin  ...[more]

Similar Datasets

| S-EPMC5623952 | biostudies-literature
| S-EPMC8631164 | biostudies-literature
| S-EPMC5556701 | biostudies-other
| PRJNA603847 | ENA
| PRJNA603846 | ENA
| S-EPMC8986289 | biostudies-literature
| S-EPMC3345810 | biostudies-other
| S-EPMC6230963 | biostudies-literature
| S-EPMC1594642 | biostudies-literature
| S-EPMC9400409 | biostudies-literature